RT Journal Article
SR Electronic
T1 EP1064 Clinical and pathologic findings of risk-reducing surgery in high-risk breast/ovarian cancer women
JF International Journal of Gynecologic Cancer
JO Int J Gynecol Cancer
FD BMJ Publishing Group Ltd
SP A560
OP A560
DO 10.1136/ijgc-2019-ESGO.1106
VO 29
IS Suppl 4
A1 M Cardoso
A1 C Reis de Carvalho
A1 J Aquino
A1 L Correia
A1 B López
A1 M Bernardino
A1 AF Jorge
YR 2019
UL http://ijgc.bmj.com/content/29/Suppl_4/A560.1.abstract
AB Introduction/Background Inherited germline mutations in BRCA1/BRCA2 increase significantly the risk of developing breast and ovarian cancers. For women in whom a BRCA pathogenic variant is identified, risk-reducing bilateral salpingo-oophorectomy (rrBSO) is recommend by age 35 to 40 years or when childbearing is complete. This procedure is associated with reduction of ovarian cancer risk, reduction in breast cancer, cancer-related mortality and overall mortality. The incidence of unsuspected neoplasia in these women varies in the literature.Methodology We performed a retrospective review of all women undergoing risk-reducing surgery between January 2013 and December 2018, in an oncological referral center - Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.The purpose of this study was to analyze the results of anatomo-histopathologic examinations and to identify the rate of occult cancer diagnosis in a high-risk population.Results Overall, 83 high-risk women (75 known BRCA1/2 carriers; 8 with unknown mutation status) underwent risk-reducing surgery. The median age at the surgery was 48,76 years and the median body mass index was 25,65 kg/m2. 42,2% (n=35) of these women had personal history of breast cancer. Preoperative CA-125 levels were considered normal in 97,6%(n=81).We performed rrBSO on 22,89%(n=19) of cases and concomitant hysterectomy on 77,1%(n=64). Laparoscopic approach was used in 77,1%(n=64) of procedures. The surgical complication rate was 3.6%(n=3).The anatomopathological analysis of specimens revealed: 5 ovarian serous cystadenoma, 1 adenomatoid tumor of the fallopian tube, 1 ovarian cystic teratoma and 1 ovarian endometrioma. The presence of occult tumor cells, including epithelial ovarian cancer and serous tubal intraepithelial carcinoma, was not reported.Conclusion Risk-reducing surgery is a safe and effective strategy to manage BRCA mutation carriers. Even though our median age at surgery is high, the incidence of unsuspected neoplasia identified in this study was unexpectedly low compared with the current literature.Disclosure Nothing to disclose